Pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: Real-life clinical experience

被引：0
|
作者：
Poblete, S. [1 ]
Caulkins, M. A. [2 ]
Roche, C. L. [3 ]
Loecher, A. [1 ]
Attwood, K. [4 ]
Gaulin, N. [2 ]
Mager, K. [2 ]
Frederick, P. [2 ]
Zsiros, E. [2 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Pharm, Buffalo, NY USA
[2] Roswell Pk Comprehens Canc Ctr, Gynecol Oncol, Buffalo, NY USA
[3] Roswell Pk Comprehens Canc Ctr, Radiol, Buffalo, NY USA
[4] Roswell Pk Comprehens Canc Ctr, Biostat, Buffalo, NY USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.697
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
569P
引用
收藏
页码：S807 / S807
页数：1
相关论文
共 50 条
  • [1] A phase II trial of pembrolizumab in combinationwith bevacizumab and oral metronomic cyclophosphamide for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
    Zsiros, E.
    Frederick, P. J.
    Akers, S. N.
    Attwood, K.
    Wang, K.
    Lele, S. B.
    Odunsi, K.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 23 - 23
  • [2] Oral cyclophosphamide plus bevacizumab in recurrent ovarian, fallopian tube and primary peritoneal cancer
    Eyada, Mostafa
    Michael, Victoria
    Fellman, Bryan M.
    Patel, Shrina
    Soliman, Pamela T.
    How, Jeffrey Andrew
    Jazaeri, Amir A.
    Fleming, Nicole D.
    Sood, Anil K.
    Westin, Shannon Neville
    Sims, Travis T.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] BEVACIZUMAB IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER: A SINGLE CENTRE EXPERIENCE
    Ngu, S. F.
    Chan, K.
    Tse, K. Y.
    Chu, M.
    Ngan, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1611 - 1611
  • [4] Efficacy and Safety of Pembrolizumab in Combination With Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer A Phase 2 Nonrandomized Clinical Trial
    Zsiros, Emese
    Lynam, Sarah
    Attwood, Kristopher M.
    Wang, Chong
    Chilakapati, Shanmuga
    Gomez, Eduardo Cortes
    Liu, Song
    Akers, Stacey
    Lele, Shashikant
    Frederick, Peter J.
    Odunsi, Kunle
    JAMA ONCOLOGY, 2021, 7 (01) : 78 - 85
  • [5] Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients
    Attianese, Daniela
    Massobrio, Roberta
    Giorgi, Margherita
    Villa, Michela
    Fuso, Luca
    Badellino, Enrico
    Bellero, Marco
    Ferrero, Annamaria
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 310 (04) : 2183 - 2190
  • [6] COMBINATION THERAPY OF ORAL CYCLOPHOSPHAMIDE AND BEVACIZUMAB FOR PATIENTS WITH RECURRENT OVARIAN AND PERITONEAL CANCER
    Goto, M.
    Takimoto, Y.
    Isono, R.
    Yamashita, M.
    Onoue, M.
    Yoshioka, E.
    Tashima, R.
    Hori, K.
    Tsubamoto, H.
    Ito, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A126 - A126
  • [7] Combination therapy of oral cyclophosphamide and bevacizumab for patients with recurrent ovarian and peritoneal cancer
    Goto, Mayako
    Tsubamoto, Hiroshi
    Isono-Taniguchi, Roze
    Takimoto, Yumi
    Tashima, Lena
    Hori, Kensuke
    Ito, Kimihiko
    MEDICINE, 2023, 102 (08) : E32880
  • [8] Randomized pilot trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer: preliminary data
    Chung, V. M.
    Ruel, C.
    Cristea, M.
    Luu, T. H.
    Leong, L.
    McNamara, M.
    Martel, C.
    Lim, D.
    Twardowski, P.
    Morgan, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] EFFECTIVENESS OF ORAL ETOPOSIDE IN RECURRENT OR REFRACTORY EPITHELIAL OVARIAN CANCER, PRIMARY PERITONEAL CANCER AND FALLOPIAN TUBE CANCER
    Kongsawatvorakul, C.
    Charakorn, C.
    Chittithaworn, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 742 - 742
  • [10] Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: A retrospective observational study
    Steck, Alexandra
    Barlin, Joyce
    Timmins, Patrick
    McElrath, Timothy
    Martin, Jovana
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S244 - S244
12345